Ketamine and Chronic Pain: Insights from Medical Cannabis to Psychedelics (2023, Project CBD)
Introduction This 2023 feature from Project CBD examines a patient’s journey from federally approved medical cannabis use to integrating ketamine […]
Introduction This 2023 feature from Project CBD examines a patient’s journey from federally approved medical cannabis use to integrating ketamine […]
Introduction In this 2023 report from Project CBD, the narrative of a federal medical cannabis patient reveals how ketamine—a powerful,
Insights from Trujillo and Iñiguez, September 15, 2020 Introduction Dr. Trujillo and Dr. Iñiguez’s 2020 study provides a nuanced view
Based on the work of Trujillo and Iñiguez, September 15, 2020 Introduction What if a drug known for its role
Introduction Severe traumatic brain injury (TBI) can leave patients and their loved ones searching for the best possible treatments to
Introduction: Wright and Kabbaj (2018) examined sex-specific differences in ketamine’s sub-anesthetic antidepressant effects and abuse liability, emphasizing the importance of
Introduction: In their 2018 study, researchers Wright and Kabbaj explored how ketamine’s antidepressant effects and potential for misuse differ between
Introduction: Megan Thielking’s STAT News article sheds light on the burgeoning industry of ketamine clinics, examining their promise in treating
Introduction: In 2018, reporter Megan Thielking explored the growing trend of ketamine treatments for severe depression in her STAT News
Introduction: Li et al. (2021), in their meta-analysis published in Journal of Affective Disorders, assessed the comparative efficacy and acceptability